Subsidies
Subsidies
subsidy
Title | Code of transcript | Funder | Beneficiary Entity | Call for applications | Date of award | Amount Awarded | Other Funds |
---|---|---|---|---|---|---|---|
Study of the p27-Cdk2 axis as a new therapeutic target to combat obesity and Alzheimer's disease during ageing. | 0011-1383-2019-00005 (PC056 ALZOBIN) | GOVERNMENT OF NAVARRA | University of Navarra | 2019 GN Centers | 17-05-2019 | 49.077,94€ | - |
Innovative nanoencapsulates with advanced functional and technological properties - NanoCaps | 0011-1383-2019-000005 PT012 | GOVERNMENT OF NAVARRA | University of Navarra | 2019 GN Centers | 17-05-2019 | 74.402,90€ | - |
Study of the p27-Cdk2 axis as a new therapeutic target for combating obesity and Alzheimer's disease during aging | 0011-1383-2019-000006 | GOVERNMENT OF NAVARRA | 2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH INSTITUTIONS | 17-05-2019 | 21.808,75€ | - | |
Identification of specific neuroinflammation patterns in alpha-synuclein-dependent neuronal death in models of Parkinson's disease. | 0011-1383-2019-000006 | GOVERNMENT OF NAVARRA | 2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH INSTITUTIONS | 17-05-2019 | 100.795,00€ | - | |
Immunotherapy strategies based on redirected T lymphocytes. | 0011-1383-2019-000006 | GOVERNMENT OF NAVARRA | 2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH INSTITUTIONS | 17-05-2019 | 102.651,25€ | - | |
Gene therapy for congenital metabolic diseases with neurological involvement: cerebrotendinous xanthomatosis. | 0011-1383-2019-000006 | GOVERNMENT OF NAVARRA | 2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH INSTITUTIONS | 17-05-2019 | 116.861,88€ | - | |
Platform for capturing vital signs in non-clinical environments. | 0011-1383-2019-000006 | GOVERNMENT OF NAVARRA | 2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH INSTITUTIONS | 17-05-2019 | 52.862,01€ | - | |
Optimization of new epigenetic agents for the treatment of acute myeloid leukemia. | 0011-1383-2019-000006 | GOVERNMENT OF NAVARRA | 2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH INSTITUTIONS | 17-05-2019 | 125.835,30€ | - | |
Glucocerebrosidase gene therapy for the treatment of Parkinson's disease. | 0011-1383-2019-000006 | GOVERNMENT OF NAVARRA | 2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH INSTITUTIONS | 17-05-2019 | 132.648,00€ | - | |
Epigenetic inhibitors and 3D printing for tendinomuscular injuries. | 0011-1383-2019-000006 | GOVERNMENT OF NAVARRA | 2019 - GN INDUSTRY PROJECTS TECHNOLOGY CENTERS AND RESEARCH INSTITUTIONS | 17-05-2019 | 126.096,23€ | - | |